Studies on animals have shown potential risks to fetal development, and there is limited human data to confirm their safety
SB: Investigation, Writing original draft, Writing review and editing
Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA
The diagrams in a and f were created using BioRender
Activates FoxO transcription factors (linked to stress resilience) Enhances mitochondrial autophagy (mitophagy) May protect against oxidative damage and aging-related decline How to Use MOTSc: Dosage, Frequency, and Timing MOTSc is typically administered as a subcutaneous injection , with cycles ranging from 2 to 4 weeks depending on goalsfat loss, performance enhancement, or metabolic reset
Dihexa is not FDA-approved for any indication and has no published human safety data